Inactivity of the bicyclic pyrimidine nucleoside analogues against simian varicella virus (SVV) does not correlate with their substrate activity for SVV-encoded thymidine kinase

Biochemical and Biophysical Research Communications

Volumn 315, Issue 4, 2004, Pages 877-883

  Sienaert, R ^a   Andrei, G ^a   Snoeck, R ^a   De Clercq, E ^a   McGuigan, C ^b   Balzarini, J ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYURIDINE; GUANOSINE; PYRIMIDINE NUCLEOSIDE; THYMIDINE KINASE;

ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; SIMIAN VIRUS; VARICELLA ZOSTER VIRUS;

CERCOPITHECINE HERPESVIRUS 9; HUMAN HERPESVIRUS 3; SAL VIEJA VIRUS; SIMIAE; VARICELLA VIRUS;

EID: 1342281674     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.136     Document Type: Article

References (24)

1. Gray W.L., Oakes J.E. Simian varicella virus DNA shares homology with human varicella-zoster virus DNA. Virology. 136:1984;241-246.
2. Fletcher III T.M., Gray W.L. Simian varicella virus: characterization of virion and infected cell polypeptides and the antigenic cross-reactivity with varicella-zoster virus. J. Gen. Virol. 73:1992;1209-1215.
3. Pumphrey C.Y., Gray W.L. The genomes of simian varicella virus and varicella-zoster virus are colinear. Virus Res. 26:1992;255-266.
4. J.E. Oakes, J.M. d'Offay, Simian varicella virus, in: Virus Diseases in Laboratory and Captive Animals, Boston, MA, 1988, pp. 163-174.
5. Mahalingam R., Smith D., Wellish M., Wolf W., Dueland A.N., Cohrs R., Soike K., Gilden D. Simian varicella virus DNA in dorsal root ganglia. Proc. Natl. Acad Sci. USA. 88:1991;2750-2752.
6. Soike K. Simian varicella infection in african and asian monkeys. Ann. NY Acad. Sci. 653:1992;323-333.
7. Davison A.J., Scott J.E. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1986;1759-1816.
8. Clarke P., Rabkin S.D., Inman M.V., Mahalingam R., Cohrs R., Wellish M., Gilden D.H. Molecular analysis of simian varicella virus DNA. Virology. 190:1992;597-605.
9. Gray W.L., Starnes B., White M.W., Mahalingam R. The DNA sequence of the simian varicella virus genome. Virology. 284:2001;123-130.
10. Pumphrey C.Y., Gray W.L. Identification and analysis of simian varicella virus thymidine kinase gene. Arch. Virol. 141:1996;43-55.
11. McGuigan C., Yarnold C.J., Jones G., Velázquez S., Barucki H., Brancale A., Andrei G., Snoeck R., De Clercq E., Balzarini J. Potent and selective inhibition of varicella-zoster (VZV) by nucleoside analogues with an unusual bicyclic base. J. Med. Chem. 42:1999;4479-4484.
12. G. Andrei, R. Sienaert, L. Naesens, E. De Clercq, C. McGuigan, J. Balzarini, R. Snoeck, Susceptibilities of several drug-resistant varicella-zoster virus (VZV) strains to bicyclic pyrimidine nucleoside analogues (BCNAs). Fifteenth International Conference on Antiviral Research, Prague, Czech Republic. Antiviral Res., 53, 2002, A59.
13. McGuigan C., Barucki H., Carangio A., Blewett S., Andrei G., Snoeck R., De Clercq E., Balzarini J. Highly potent and selective inhibition of varicella-zoster virus by bicyclic furopyrimidine nucleosides bearing an aryl side chain. J. Med. Chem. 43:2000;4993-4997.
14. McGuigan C., Brancale A., Barucki H., Srinivasan S., Jones G., Pathirana R., Blewett S., Alvarez R., Yarnold C.J., Carangio A., Velázquez S., Andrei G., Snoeck R., De Clercq E., Balzarini J. Fluorescent bicyclic furo pyrimidine deoxynucleoside analogs as potent and selective inhibitors of VZV and potential future drugs for the treatment of chickenpox and shingles. Drugs Future. 25:2000;1151-1161.
15. Balzarini J., McGuigan C. Chemotherapy of varicella-zoster virus by a novel class of highly specific anti-VZV bicyclic pyrimidine nucleosides. Biochim. Biophys. Acta. 1587:2002;287-295.
16. Sienaert R., Naesens L., Brancale A., De Clercq E., McGuigan C., Balzarini J. Specific recognition of the bicyclic pyrimidine nucleoside analogues, a new class of highly potent and selective inhibitors of varicella-zoster virus (VZV), by the VZV encoded thymidine kinase. Mol. Pharmacol. 61:2002;249-254.
17. White T.M., Gilden D.H., Mahalingam R. An animal model of varicella virus infection. Brain Pathol. 11:2001;475-479.
18. Dueland A.N., Martin J.R., Devlin M.E., Wellish M., Mahalingam R., Cohrs R., Soike K.F., Gilden D.H. Acute simian varicella infection. Clinical, laboratory, pathologic and virologic features. Lab. Invest. 66:1992;762-773.
19. Mahalingam R., Traina-Dorge V., Wellish M., Smith J., Gilden D.H. Naturally acquired simian varicella virus infection in african green monkeys. J. Virol. 76:2002;8548-8550.
20. Cihlar T., Fuller M.D., Cherrington J.M. Expression of the catalytic subunit (UL54) an the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation system. Protein Expr. Purif. 11:1997;209-218.
21. De Clercq Highly potent and selective inhibition of varicella-zoster virus replication by bicyclic furo[2,3-d]pyrimidine nucleoside analogues. Med. Res. Rev. 23:2003;253-274.
22. Kinchington P.R. Latency of varicella-zoster virus: a persistently perplexing state. Front. Biosci. 4:1999;200-211.
23. Soike K.F., Felsenfeld A.D., Gerone P.J. Acyclovir treatment of experimental simian varicella infection of monkeys. Antimicrob. Agents Chemother. 20:1981;291-297.
24. Soike K.F., Baskin G., Cantrell C., Gerone P. Investigation of antiviral activity of 1-beta-D-arabinofuranosylthymine (ara-T) and 1-beta-D- arabinofuranosyl-E-5-(2-bromovinyl)uracil (BVaraU) in monkeys infected with simian varicella virus. Antiviral Res. 4:1984;245-257.